The role of 18F-FDG-positron emission tomography/computed tomography in staging primary breast cancer

Journal of Cancer

Volumn 1, Issue 1, 2010, Pages 51-53

  Niikura, Naoki ^a   Ueno, Naoto T ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Breast cancer; Distant metastases; PET CT; Primary staging

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ASPIRATION BIOPSY; AXILLARY LYMPH NODE; BREAST CANCER; CANCER DIAGNOSIS; CANCER PATIENT; CANCER STAGING; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; DISTANT METASTASIS; ECHOMAMMOGRAPHY; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MEDLINE; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SHORT SURVEY;

EID: 84856213822     PISSN: None     EISSN: 18379664     Source Type: Journal    
DOI: 10.7150/jca.1.51     Document Type: Short Survey

References (12)

1. Carlson RW, McCormick B. Update: NCCN breast cancer clinical practice guidelines. J Natl Compr Canc Netw. 2005; 3 (Suppl 1):S7-S11.
2. Muller D, Kohler G, Ohlinger R. Staging procedures in primary breast cancer. Anticancer Res. 2008; 28:2397-400.
3. Schneider C, Fehr MK, Steiner RA, et al. Frequency and distribution pattern of distant metastases in breast cancer patients at the time of primary presentation. Arch Gynecol Obstet. 2003; 269:9-12.
4. Gerber B, Seitz E, Muller H, et al. Perioperative screening for metastatic disease is not indicated in patients with primary breast cancer and no clinical signs of tumor spread. Breast Cancer Res Treat. 2003; 82:29-37.
5. Hance KW, Anderson WF, Devesa SS, et al. Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute. J Natl Cancer Inst. 2005; 97:966-75.
6. Al-Husaini H, Amir E, Fitzgerald B, et al. Prevalence of overt metastases in locally advanced breast cancer. Clin Oncol (R Coll Radiol). 2008; 20:340-4.
7. Fuster D, Duch J, Paredes P, et al. Preoperative staging of large primary breast cancer with [18F]fluorodeoxyglucose positron emission tomography/computed tomography compared with conventional imaging procedures. J Clin Oncol. 2008; 26:4746-51.
8. Carkaci S, Macapinlac HA, Cristofanilli M, et al. Retrospective study of 18F-FDG PET/CT in the diagnosis of inflammatory breast cancer: preliminary data. J Nucl Med. 2009; 50:231-8.
9. Alberini JL, Lerebours F, Wartski M, et al. 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) imaging in the staging and prognosis of inflammatory breast cancer. Cancer. 2009; 115:5038-47.
10. Heusner TA, Kuemmel S, Umutlu L, et al. Breast cancer staging in a single session: whole-body PET/CT mammography. J Nucl Med. 2008; 49:1215-22.
11. Groheux D, Moretti JL, Baillet G, et al. Effect of (18)F-FDG PET/CT imaging in patients with clinical Stage II and III breast cancer. Int J Radiat Oncol Biol Phys. 2008; 71:695-704.
12. Ueda S, Tsuda H, Asakawa H, et al. Utility of 18F-fluoro-deoxyglucose emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in combination with ultrasonography for axillary staging in primary breast cancer. BMC Cancer. 2008; 8:165.